Work

Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC

Year: 2009

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-009-0332-2

Authors: Stephanie L. Hines, Betty Mincey, Todor Dentchev, Jeff A. Sloan, Edith A. Perez, David B. Johnson, Paul L. Schaefer, Steve Alberts, Heshan Liu, Stephen Kahanic, Miroslaw A. Mazurczak, Daniel A. Nikcevich, Charles L. Loprinzi

Institutions: Mayo Clinic, Mayo Clinic in Florida, Altru Health System

Language: English

Topic: Bone health and treatments

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: G1423238671, G1539327064, Sanford Community Cancer Consortium, G358241105, G3737421695, G3789417232, G3933064421, G42877212, TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM, Community Clinical Oncology Program, North Central Cancer Treatment Group, Survivorship research established investigator award, Community Clinical Oncology Program, Duluth Community Clinical Oncology Program

OpenAlex ID: W2042697602

FWCI: 4.493

Cites: 16

Cited by: 84

Related to: 10